The positive impact of biologic medicines for the treatment of many chronic diseases, such as multiple sclerosis, HIV, hepatitis C, Rheumatoid arthritis and others, cannot be understated. That’s why it’s good news that soon patients and prescribers will have access to cutting edge medicines called biosimilars.